Products
Preparation registered in Ukraine
Comorbidity of diabetes and liver disease
The study examined dynamics of clinical manifestations, blood biochemical parameters (bilirubin, ALT, AST), concomitant liver diseases in patients with diabetes and cytolytic syndrome on the background of Alpha-Lipon (Kyiv Vitamin Factory) therapy, and evaluated its tolerability. Fifty patients with type 2 diabetes and cytolytic syndrome were randomized into 2 groups: group 1 received tableted hypoglycemic drugs and Alpha-Lipon (600 mg/d, or 2 capsules) in the morning for 8 weeks, group 2 received only standard treatment of diabetes. Alpha-Lipon demonstrated efficacy in treating patients with a combination of diabetes and cytolytic syndrome: positive effect on biochemical parameters (levels of ALT, AST, bilirubin), blood sugar, more rapid elimination of asthenovegetative, dyspeptic and pain syndrome symptoms. Alpha-Lipon demonstrated good safety and tolerability profile.
Keywords: diabetes, liver, risk factors, alpha lipoic acid, Alpha-Lipon.